Blank fields on this form indicate the information is unknown, unchanged, or unavailable.Summary of event: it was reported that a turbo-ject single lumen minocycline/rifampin over-the-wire power-injectable picc broke where the extension tubing and hub connect.No procedures were being performed via the device.The patient required removal and replacement of the picc line due to the catheter breakage.In regard to patient hospitalization/prolonged hospitalization, it was noted that there was a delay due to the new line being placed.No power injection was being used.Investigation evaluation: a review of the complaint history, device history record, instructions for use (ifu), and quality control procedures was conducted during the investigation.A visual inspection and functional test of the complaint device was also conducted.One single-lumen upic was received in a used condition.There is a hole in the extension tubing at the hub joint.A leak test was performed, confirming a leak at this hole.A document-based investigation evaluation was performed.Although lot information is unknown, three possible lots were identified during a search of sales records.A review of the potential lots and related subassembly lots found no related nonconformances.A database search revealed no other complaints on the possible lots.The information provided upon review of the dmr, ifu, dhr, dhf, and investigation of the returned device suggests that the device was manufactured to specification.There is no evidence of nonconforming devices from the complaint lot in-house or in the field.The product ifu states that the device is indicated for short- or long-term use for venous pressure monitoring, blood sampling, administration of drugs and fluids, and for use with power injectors for delivery of contrast in ct studies.The ifu instructs to inspect the product upon removal from the package, to ensure no damage has occurred.Cook has concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.Based on the information provided and the results of the investigation, cook was unable to make a definitive conclusion for the cause of this event.There is currently a capa investigation open to investigate this product failure mode.The risk analysis for this failure mode was reviewed and no additional escalation was required.The appropriate personnel have been notified and cook will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|